当前位置:首页 - 行情中心 - 中国医药(600056) - 财务分析

中国医药

(600056)

  

流通市值:163.14亿  总市值:163.20亿
流通股本:14.95亿   总股本:14.96亿

中国医药(600056)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润5.89亿元,每股收益0.30元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1429090.52万元,未分配利润792571.17万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产3698758.53万元,负债2269668.01万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入25,894,435,068.4717,075,860,112.168,262,744,582.7534,148,359,638.99
营业总成本24,983,221,781.216,438,279,511.827,973,445,487.2832,983,445,215.42
其他经营收益
营业利润823,762,646.19524,870,248.86304,650,879.12931,567,858.53
利润总额822,447,705.46520,722,428.39304,613,642.69953,188,513.89
净利润588,710,745.06375,327,120.46227,200,028.63686,623,882.02
每股收益
其他综合收益613,986.042,628,805.36884,977.29-362,481.48
综合收益总额589,324,731.1377,955,925.82228,085,005.92686,261,400.54
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计28,050,937,670.5327,822,270,967.0626,788,148,856.2927,414,324,032.9
非流动资产:
非流动资产合计8,936,647,655.788,889,673,571.338,902,906,995.768,911,001,979.37
资产总计36,987,585,326.3136,711,944,538.3935,691,055,852.0536,325,326,012.27
流动负债:
流动负债合计19,648,179,014.119,653,490,408.1217,223,758,138.3818,002,293,620.24
非流动负债:
非流动负债合计3,048,501,112.72,930,488,687.734,127,982,443.793,993,465,112.13
负债合计22,696,680,126.822,583,979,095.8521,351,740,582.1721,995,758,732.37
所有者权益(或股东权益):
归属于母公司股东权益合计11,852,956,503.4711,723,575,812.9111,987,780,202.6112,032,631,883.39
股东权益合计14,290,905,199.5114,127,965,442.5414,339,315,269.8814,329,567,279.9
负债和股东权益合计36,987,585,326.3136,711,944,538.3935,691,055,852.0536,325,326,012.27
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计26,276,960,397.4317,344,751,244.357,438,600,455.4236,243,984,709.68
经营活动现金流出小计26,589,498,198.4417,890,884,215.888,920,176,697.8435,238,554,160.06
经营活动产生的现金流量净额-312,537,801.01-546,132,971.53-1,481,576,242.421,005,430,549.62
投资活动产生的现金流量:
投资活动现金流入小计27,940,922.3927,549,739.828,187,430.1943,843,014.21
投资活动现金流出小计213,772,988.8129,115,639.6865,496,987.21411,499,628.29
投资活动产生的现金流量净额-185,832,066.41-101,565,899.86-57,309,557.02-367,656,614.08
筹资活动产生的现金流量:
筹资活动现金流入小计3,427,503,979.322,300,104,191.341,475,926,683.576,492,003,159.82
筹资活动现金流出小计4,543,313,803.723,025,074,766.631,429,227,227.676,750,237,069.63
筹资活动产生的现金流量净额-1,115,809,824.4-724,970,575.2946,699,455.9-258,233,909.81
汇率变动对现金及现金等价物的影响-4,976,557.26-1,024,669.09-842,648.331,779,865.31
现金及现金等价物净增加额-1,619,156,249.08-1,373,694,115.77-1,493,028,991.87381,319,891.04
期末现金及现金等价物余额2,237,993,441.392,483,455,574.72,218,549,837.943,711,578,829.81
补充资料:
现金及现金等价物的净增加额--1,373,694,115.77-381,319,891.04
TOP↑